Home > Áreas Terapéuticas > HEPATOLOGÍA > Buti M, Manzano ML, Morillas RM, García-Retortillo M, Martin L, Prieto M, Gutiérrez ML, Suarez E, Gómez-Rubio M, López J, Castillo P, Rodríguez M, Zozaya JM, Simón MA, Morano LE, Calleja JL, Yébenes M, Esteban R

Buti M, Manzano ML, Morillas RM, García-Retortillo M, Martin L, Prieto M, Gutiérrez ML, Suarez E, Gómez-Rubio M, López J, Castillo P, Rodríguez M, Zozaya JM, Simón MA, Morano LE, Calleja JL, Yébenes M, Esteban R

Buti M, Manzano ML, Morillas RM, García-Retortillo M, Martin L, Prieto M, Gutiérrez ML, Suarez E, Gómez-Rubio M, López J, Castillo P, Rodríguez M, Zozaya JM, Simón MA, Morano LE, Calleja JL, Yébenes M, Esteban R

 

Randomized prospective study evaluating tenofovir disoproxil fumarate prophylaxis against hepatitis B virus reactivation in anti- HBc-positive patients with rituximab-based regimens to treat hematologic malignancies: The Preblin study
Plos One 2017. Doi.org/10.1371/journal.pone.0184550